BamSEC and AlphaSense Join Forces
Learn More

Aprea Therapeutics Inc. – Indentures

NASDAQ: APRE    
Share price (11/19/26): $0.49    
Market cap (11/19/26): $6.998 million

Indentures Filter

EX-4.2
from 8-K 13 pages Aprea Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 13 pages Pre-Funded Common Stock Purchase Warrant Aprea Therapeutics, Inc
12/34/56
EX-4.2
from 8-K 13 pages Aprea Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 13 pages Pre-Funded Common Stock Purchase Warrant Aprea Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 13 pages Aprea Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.2
from 8-K 13 pages Aprea Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 13 pages Pre-Funded Common Stock Purchase Warrant Aprea Therapeutics, Inc
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 28 pages Aprea Therapeutics, Inc. Tranche B Warrant to Purchase Common Stock or Exchange Warrants
12/34/56
EX-4.2
from 8-K 27 pages Aprea Therapeutics, Inc. Tranche a Warrant to Purchase Common Stock or Exchange Warrants
12/34/56
EX-4.1
from 8-K 13 pages Pre-Funded Common Stock Purchase Warrant Aprea Therapeutics, Inc
12/34/56
EX-4.1
from S-3 28 pages Aprea Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-8 2 pages Atrin Pharmaceuticals, LLC Amendment No. 1 to the 2016 Amended and Restated Equity Compensation Plan February 2, 2022
12/34/56
EX-4.3
from S-8 14 pages Atrin Pharmaceuticals LLC 2016 Amended and Restated Equity Compensation Plan Atrin Pharmaceuticals LLC 2016 Amended and Restated Equity Compensation Plan
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3 38 pages Aprea Therapeutics, Inc. Indenture Dated as of , 20 [ ] Trustee
12/34/56
EX-4.1
from 10-K 3 pages Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 1 page Indenture or similar
12/34/56